Your browser doesn't support javascript.
loading
Dose of intra-operative opioids has no impact on recurrence or survival in primary liver cancer.
Zhao, Liuyuan; Teng, Lei; Zhang, Wenhui; Lin, Shiyan; Liu, Xuejiao; Dai, Junzhu; Shao, Hongxue; Li, Xiaoshi; Liu, Quan; Zou, Huichao.
Afiliación
  • Zhao L; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
  • Teng L; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
  • Zhang W; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
  • Lin S; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
  • Liu X; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
  • Dai J; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
  • Shao H; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
  • Li X; Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • Liu Q; Department of Biochemistry, School of Medicine, Southern University of Science and Technology, Shenzhen, China.
  • Zou H; Department of Pain Medicine, Harbin Medical University Cancer Hospital, Harbin, China.
Cancer Med ; 11(24): 4927-4934, 2022 12.
Article en En | MEDLINE | ID: mdl-35588234
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Cancer Med Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Cancer Med Año: 2022 Tipo del documento: Article